Louise Emmett, MD

Louise Emmett, MD

Louise Emmett, MD, is director of theranostics and nuclear medicine at St. Vincent’s Hospital, Sydney

Articles by Louise Emmett, MD

ENZA-p: Predictive, Prognostic Value of Baseline PSMA Total Tumor Volume, SUV Mean

Louise Emmett, MDRLT | May 31, 2025

Louise Emmett, MD, discusses the ENZA-p trial which studied enzalutamide versus enzalutamide plus [177Lu] Lu-PSMA-617.

Co-PSMA Trial: Head-to-Head Comparison of 64Cu-SAR-bis-PSMA vs 68Ga-PSMA-11

Louise Emmett, MDProstate Cancer Diagnostics | March 24, 2025

Dr. Emmett discusses the Co-PSMA trial, comparing ⁶⁴Cu-SAR-bisPSMA and ⁶⁸Ga-PSMA-11 for detecting prostate cancer ...